A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone

Journal of Clinical Oncology

Volumn 24, Issue 15, 2006, Pages 2227-2229

  Kominsky, Scott L ^a   Davidson, Nancy E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; PAMIDRONIC ACID; PLACEBO; RADIOPHARMACEUTICAL AGENT; STRONTIUM 89; ZOLEDRONIC ACID; TUMOR MARKER;

BONE MARROW SUPPRESSION; BONE METASTASIS; BONE NECROSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EDITORIAL; GENE EXPRESSION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; JAW OSTEONECROSIS; LABORATORY TEST; LYMPH NODE METASTASIS; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PAIN; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; VALIDATION STUDY; BONE TUMOR; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METASTASIS; NOTE; PATHOLOGY; PREDICTION AND FORECASTING; TUMOR CELL LINE;

BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DIPHOSPHONATES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TUMOR MARKERS, BIOLOGICAL;

EID: 33744817388     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.5319     Document Type: Editorial

References (21)

1. Lee CK, Aeppli DM, Unger J, et al: Strontium-89 chloride (Metastron) for palliative treatment of bony metastases: The University of Minnesota experience. Am J Clin Oncol 19:102-107, 1996
2. Powsner RA, Zietman AL, Foss FM: Bone marrow suppression after strontium-89 therapy and local radiation therapy in patients with diffuse marrow involvement. Clin Nucl Med 22:147-150, 1997
3. Banerjee D, Asif A, Striker L, et al: Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity. Am J Kidney Dis 41:E18, 2003
4. Markowitz GS, Fine PL, Stack JI, et al: Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281-289, 2003
5. Bamias A, Kastritis E, Bamia C, et al: Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 23:8580-8587, 2005
6. Smid M, Wang Y, Klijn JGM, et al: Genes associated with breast cancer metastasizing to bone. J Clin Oncol 24:2261-2267, 2006
7. Wang Y, Klijn JG, Zhang Y, et al: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671-679, 2005
8. van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
9. Minn AJ, Gupta GP, Siegel PM, et al: Genes that mediate breast cancer metastasis to lung. Nature 436:518-524, 2005
10. Montel V, Huang TY, Mose E, et al: Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol 166:1565-1579, 2005
11. Kang Y, Siegel PM, Shu W, et al: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549, 2003
12. Prest SJ, May FE, Westley BR: The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 16:592-594, 2002
13. Rodrigues S, Van Aken E, Van Bocxlaer S, et al: Trefoil peptides as proangiogenic factors in vivo and in vitro: Implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 17:7-16, 2003
14. Kinoshita K, Taupin DR, Itoh H, et al: Distinct pathways of cell migration and antiapoptotic response to epithelial injury: Structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680-4690, 2000
15. Woelfle U, Cloos J, Sauter G, et al: Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63:5679-5684, 2003
16. Guise TA, Yin JJ, Taylor SD, et al: Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544-1549, 1996
17. Bendre MS, Gaddy-Kurten D, Mon-Foote T, et al: Expression of intereukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62:5571-5579, 2002
18. Pecheur I, Peyruchaud O, Serre CM, et al: Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 16:1266-1268, 2002
19. Saarto T, Vehmanen L, Virjunen P, et al: Ten-year followup of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. Acta Oncol 44:80-82, 2005
20. Powles T, Paterson S, Kanis JA, et al: Randomized placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 20:3219-3224, 2002
21. Diel IJ, Solomayer ER, Costa SD, et al: Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339:357-363, 1998